{"id":9052,"date":"2018-04-18T06:01:02","date_gmt":"2018-04-18T06:01:02","guid":{"rendered":"http:\/\/contenidosportal.sld.cu\/portal20142020\/?p=3030"},"modified":"2018-04-18T06:01:02","modified_gmt":"2018-04-18T06:01:02","slug":"ensayo-clinico-de-fase-i-con-el-cigb-814-para-el-tratamiento-de-la-artritis-reuma","status":"publish","type":"post","link":"https:\/\/contenidosportal.sld.cu\/portal20142020\/2018\/04\/18\/ensayo-clinico-de-fase-i-con-el-cigb-814-para-el-tratamiento-de-la-artritis-reuma\/","title":{"rendered":"Ensayo cl\u00ednico de fase I con el CIGB 814 para el tratamiento de la artritis reumatoide: Seguridad, farmacocin\u00e9tica y efectos terap\u00e9uticos preliminares"},"content":{"rendered":"<div class=\"imagen-node-pie\">\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"imagefield imagefield-field_imagen\" alt=\"\" src=\"http:\/\/contenidosportal.sld.cu\/files2014-2020\/imagen\/17\/journal-of-clinical-trials_noticia_ampliada.jpg\" width=\"242\" height=\"305\"><\/div>\n<div class=\"item-node\">\n<div class=\"cw-content-description cw-content-wysiwygtext\">\n<p><a href=\"http:\/\/www.omicsonline.org\/peer-reviewed\/pphase-i-clinical-trial-with-a-novel-altered-peptide-ligand-derived-from-human-heatshock-protein-60-for-treatment-of-rheumatoid-ar-98936.html\" target=\"_blank\" rel=\"noopener\"><strong>Phase I Clinical Trial with a Novel Altered Peptide Ligand Derived from Human Heat-Shock Protein 60 for Treatment of Rheumatoid Arthritis: Safety, Pharmacokinetics and Preliminary Therapeutic Effects<\/strong>.<\/a> Prada D, G&oacute;mez J, Lorenzo N, Corrales O, L&oacute;pez A et al. <a href=\"https:\/\/www.omicsonline.org\/clinical-trials.php\" target=\"_blank\" rel=\"noopener\">J Clin Trials.<\/a> 2018; 8: 339. DOI: 10.4172\/2167-0870.1000339<\/p>\n<p>El CIGB 814 es un ligando de p&eacute;ptido alterado de un ep&iacute;topo de c&eacute;lulas T CD4 + de la prote&iacute;na de choque t&eacute;rmico humano 60 (HSP60). Este autoant&iacute;geno se ha implicado en la patog&eacute;nesis de la artritis reumatoide.<\/p>\n<p>El presente ensayo cl&iacute;nico (fase I) fue realizado por investigadores del Centro Nacional referente para las enfermedades reum&aacute;ticas (Hospital Cl&iacute;nico Quir&uacute;rgico &quot;10 de Octubre&quot;), del <a href=\"http:\/\/www.cigb.edu.cu\/es\/\">Centro de Ingenier&iacute;a Gen&eacute;tica y Biotecnolog&iacute;a<\/a> (CIGB), del<a href=\"http:\/\/instituciones.sld.cu\/cencec\/\"> Centro nacional coordinador de ensayos cl&iacute;nicos<\/a> (CENCEC) y del <a href=\"http:\/\/instituciones.sld.cu\/cimeq\/\">Centro de Investigaciones M&eacute;dico Quir&uacute;rgicas <\/a>(Cimeq). Su principal objetivo fue evaluar la seguridad y la farmacocin&eacute;tica del CIGB-814 en pacientes con artritis reumatoide.<\/p>\n<p>Como conclusi&oacute;n se obtuvo que el tratamiento fue bien tolerado en todas las dosis. Solo se observaron eventos leves. El estudio de farmacocin&eacute;tica mostr&oacute; que CIGB-814 alcanz&oacute; la concentraci&oacute;n m&aacute;xima en plasma en 30 min y se elimin&oacute; principalmente despu&eacute;s de 4 h. Asimismo, el p&eacute;ptido mostr&oacute; evidencias preliminares de eficacia cl&iacute;nica que respaldan la investigaci&oacute;n cl&iacute;nica futura para el tratamiento de la artritis reumatoide.<\/p>\n<\/div>\n<\/div>\n<div class=\"clear\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Phase I Clinical Trial with a Novel Altered Peptide Ligand Derived from Human Heat-Shock Protein 60 for Treatment of Rheumatoid Arthritis: Safety, Pharmacokinetics and Preliminary Therapeutic Effects. Prada D, G&oacute;mez J, Lorenzo N, Corrales O, L&oacute;pez A et al. J Clin Trials. 2018; 8: 339. DOI: 10.4172\/2167-0870.1000339 El CIGB 814 es un ligando de p&eacute;ptido [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-9052","post","type-post","status-publish","format-standard","hentry","category-anuncio"],"_links":{"self":[{"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/posts\/9052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/comments?post=9052"}],"version-history":[{"count":0,"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/posts\/9052\/revisions"}],"wp:attachment":[{"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/media?parent=9052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/categories?post=9052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/tags?post=9052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}